97284 ⎘
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL Framework region [FR]
Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
#1202LIGANDS THAT BIND TGF-BETA RECEPTOR II
#1203Anti-CD303 monoclonal antibodies
#1204Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
#1205ANTI-WALL TEICHOIC ANTIBODIES AND CONJUGATES
#1206METHOD OF INHIBITION OF LEUKEMIC STEM CELLS
#1207Monoclonal anti-GPC-1 antibodies and uses thereof
#1208Stable and soluble antibodies inhibiting VEGF
#1209Cell line overexpressing human CD303 antigen
#1210NOVEL HUMANIZED ADAM17 ANTIBODY
#1211BINDING MEMBERS OF INTERLEUKIN-4 RECEPTOR ALPHA (IL4-Ra)
#1212Anti-Tim-3 antibodies
#1213ANTI-NOTCH2 NRR ANTIBODIES
#1214Nucleic acids encoding, and methods of producing, antibodies specific for transforming growth factor (TGF)-β
#1215Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40L
#1216Anti-PD-1 checkpoint inhibitor antibodies that block binding of PD-L1 to PD-1
#1217Anti-TNFα binding compounds and uses thereof
#1218Chimeric antigen receptor (CAR) comprising a CD19-binding domain
#1219Modified-IgG antibodies that bind transforming growth factor-β1 with high affinity, avidity and specificity
#1220Glycosylated immunoglobulin single variable domains
#1221PERTUZUMAB VARIANTS AND EVALUATION THEREOF
#1222PERTUZUMAB VARIANTS AND EVALUATION THEREOF
#1223Pertuzumab variants and evaluation thereof
#1224Methods and compositions for treating and/or preventing a disease or disorder associated with abnormal level and/or activity of the IFP35 family of proteins
#1225Antibodies, compositions, and immunohistochemistry methods for detecting C4.4a
#1226HUMANZIED FILOVIRUS ANTIBODIES AND USES THEREOF
#1227NOVEL ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) BINDING AGENTS AND USES THEREOF
#1228Monoclonal antibodies to progastrin and their uses
#1229Humanized antibodies that recognize alpha-synuclein
#1230Anti-wall teichoic antibodies and conjugates
#1231METHODS OF IDENTIFYING AND VALIDATING AFFINITY REAGENTS
#1232POLYPEPTIDES
#1233Anti-transferrin receptor antibodies and methods of use
#1234PD-L1-specific antibodies and methods of using the same
#1235Anti-PD-L1 antibodies
#1236Neutralizing GP41 antibodies and their use
#1237Methods for producing optimised therapeutic molecules
#1238BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES AND METHODS OF USE
#1239Mice expressing a limited immunoglobulin light chain repertoire
#1240ANTI-VEGF ANTIBODIES
#1241Single domain serum albumin binding protein
#1242Human TNFRSF25 antibody
#1243ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIVATIVES THEREOF FOR USE IN TREATING BONE ASSOCIATED PAIN
#1244Antibodies and immunocytokines
#1245METHOD FOR PREPARING NOVEL ANTIBODY LIBRARY AND LIBRARY PREPARED THEREBY
#1246Anti-TNFRSF25 antibodies
#1247Anti-GPIIB/IIIA antibodies and uses thereof
#1248Bispecific antibodies against CD3 and CD20
#1249TEM8 antibodies and their use in treatment and detection of tumors
#1250Anti-Axl antagonistic antibodies
#1251Engineered anti-TGF-β antibodies and antigen-binding fragments
#1252Sequences directed against hepatocyte growth factor (HGF) and polypeptides comprising the same for the treatment of cancers and/or tumors
#1253Single domain serum albumin binding protein
#1254Anti P2X7 receptor antibodies and fragments thereof
#1255Anti-TNF-α fully human monoclonal antibodies with low immunogenicity and application thereof
#1256Antibodies against human CSF-1R and uses thereof
#1257VH SCAFFOLD
#1258COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY
#1259Compositions and methods of use for augmented immune response and cancer therapy
#1260Antibodies against OX40 and uses thereof
#1261ALK7 binding proteins and uses thereof
#1262Monoclonal antibodies to progastrin and their uses
#1263Monoclonal antibodies to progastrin and their uses
#1264Anti-tenascin C antibodies and uses thereof
#1265Methods of treating RSV infections
#1266Inhalation device for use in aerosol therapy of respiratory diseases
#1267Bispecific antibodies for use in stem cell transplantation
#1268Antibodies that bind Ebola glycoprotein and uses thereof
#1269Antibody binding to neuropilin 1 and use thereof
#1270Methods of modifying antibodies for purification of bispecific antibodies
#1271STABLE ANTI-IL-4Ra FORMULATION
#1272Humanized anti-CD22 antibody
#1273Serum albumin binding proteins containing immunoglobulin single variable domains
#1274Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
#1275POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS
#1276Protein A Binding Polypeptides, Anti-EphA2 Antibodies and Methods of Use Thereof
#1277ANTI-MICA ANTIBODIES
#1278Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
#1279Antibodies against CD73
#1280Anti-GD2 antibodies
#1281Methods of Suppressing Rheumatoid Arthritis Using An Anti-IL-6 Antibody
#1282Bispecific binding molecules binding to VEGF and Ang2
#1283Humanized anti-hepcidin antibodies and uses thereof
#1284Internalizing human monoclonal antibodies targeting prostate and other cancer cells
#1285Antibodies, compositions, and uses
#1286Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
#1287Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
#1288Antagonist antibodies directed against calcitonin gene-related peptide
#1289Antagonist antibodies directed against calcitonin gene-related peptide
#1290Humanized antibodies that recognize alpha-synuclein
#1291MODIFIED VARIABLE DOMAIN MOLECULES AND METHODS FOR PRODUCING THEM
#1292ANTI-B7-H4 ANTIBODIES AND IMMUNOCONJUGATES
#1293ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR
#1294Anti-Clusterin Antibodies and Antigen Binding Fragments and their Use to Reduce Tumor Volume
#1295POLYNUCLEOTIDES ENCODING ANTI-NOTCH1 NRR ANTIBODY POLYPEPTIDES
#1296C10RF32 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER
#1297Anti-complement C1s antibodies
#1298Methods for treating multiple myeloma
#1299ANTI-ALPHA-V INTEGRIN ANTIBODY FOR THE TREATMENT OF PROSTATE CANCER
#1300Collection and methods for its use
#1301Methods of treating TTP with immunoglobulin single variable domains and uses thereof
#1302Chimeric antigen receptors targeting epidermal growth factor receptor variant III
#1303Antibody binding to FcRn for treating autoimmune diseases
#1304Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
#1305MUC1* ANTIBODIES
#1306Anti-FGFR3 antibodies and methods using same
#1307CD33 antibodies and use of same to treat cancer
#1308ANTI-NOTCH2 NRR ANTIBODIES
#1309Therapy for filovirus infection
#1310Compositions comprising resurfaced cell-penetrating nanobodies and methods of use thereof
#1311Semi-synthetic nurse shark VNAR libraries for making and using selective binding compounds
#1312Nucleic acid encoding anti-IL-17A antibodies
#1313USES OF ANTI-HER3 ANTIBODIES FOR TREATING CANCER
#1314Human immunodeficiency virus neutralizing antibodies
#1315HUMAN-DERIVED ANTI-HUMAN IL-20 ANTIBODIES AND ASSAY FOR THE IDENTIFICATION OF ANTI-CYTOKINE ANTIBODIES
#1316Opioid receptor binding agents and uses thereof
#1317Antigens associated with endometriosis, psoriatic arthritis and psoriasis
#1318Internalizing moieties
#1319Biparatopic polypeptides antagonizing Wnt signaling in tumor cells
#1320Monoclonal antibodies to progastrin and their uses
#1321Methods of treating a tauopathy
#1322Anti-CGRP compositions and use thereof
#1323Antibodies for epidermal growth factor receptor 3 (HER3)
#1324Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders
#1325Method of treating retinopathy with an anti-LRP5 antibody
#1326ANTIBODIES AGAINST THE RGM A PROTEIN AND USES THEREOF
#1327Methods of treating a kit-associated cancer by administering anti-kit antibodies
#1328IMMUNOGLOBULIN VARIANTS AND USES THEREOF
#1329HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1)
#1330Humanized antibodies with increased stability
#1331Anti-CD19 Antibodies
#1332Antigen binding proteins to oncostatin M (OSM)
#1333Antibodies recognizing α-synuclein
#1334Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
#1335Anti-indoleamine 2,3-dioxygenase 1 antibodies and diagnostic uses thereof
#1336BIOLOGICAL PRODUCTS
#1337Anti-factor D antibodies and conjugates
#1338Anti-MCAM antibodies and associated methods of use
#1339HUMANIZED ANTIBODIES
#1340LIGAND
#1341Targeted binding agents against B7-H1
#1342Epitope tag and method for detection and/or purification of tagged polypeptides
#1343Antibody, epitope tag and method for detection, capture and/or purification of tagged polypeptides
#1344NEUTRALIZING MOLECULES TO VIRAL ANTIGENS
#1345Anti-IL-6 Receptor Antibody
#1346Immunoglobulin variable domains
#1347Anti-transthyretin antibodies
#1348Antibodies recognizing medin
#1349High affinity antibodies that neutralize enterotoxin B
#1350TEM8 ANTIBODIES AND METHODS OF USE
#1351MONOCLONAL ANTIBODIES AGAINST THE RGM A PROTEIN FOR USE IN THE TREATMENT OF RETINAL NERVE FIBER LAYER DEGENERATION
#1352Anti-Axl antibodies
#1353Anti-PD-L1 antibodies, compositions and articles of manufacture
#1354ANG2-BINDING MOLECULES
#1355Heavy chain only antibodies to ANG-2
#1356Antibodies to tau and methods of treatment therewith
#1357Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
#1358Animal Models and Therapeutic Molecules
#1359Animal Models and Therapeutic Molecules
#1360Carbohydrate antibodies, pharmaceutical compositions and uses thereof
#1361Animal Models and Therapeutic Molecules
#1362Solubility optimization of immunobinders
#1363SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR
#1364Optimized variants of anti-VEGF antibodies and methods of treatment thereof by reducing or inhibiting angiogenesis
#1365Single domain binding molecule
#1366Pyrrolobenzodiazepine antibody drug conjugates and methods of use
#1367T cell receptor-like antibodies specific for a WTI peptide presented by HLA-A2
#1368PD-1 binding proteins and methods of use thereof
#1369Anti-tigit antibodies and methods of use
#1370Therapy for filovirus infection
#1371Antibodies that bind colony stimulating factor 1 receptor (CSF1R)
#1372TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#1373Humanized monoclonal antibodies and methods of use
#1374Cell penetrating anti-guanosine antibody based therapy for cancers with Ras mutations
#1375Compositions and methods for the diagnosis and treatment of tumor
#1376Anti-activin A antibodies and uses thereof
#1377Enhanced delivery of drugs to the brain
#1378ANIMAL MODELS AND THERAPEUTIC MOLECULES
#1379Gram-positive bacteria specific binding compounds
#1380Method for mass humanization of non-human antibodies
#1381Anti-IL-17A Antibodies
#1382ST2L antagonists and methods of use
#1383Antibodies to TGF-beta
#1384Monoclonal antibodies that neutralize a norovirus
#1385Anti-CD79B antibodies and immunoconjugates and methods of use
#1386Anti-transthyretin antibodies
#1387Anti-vista antibodies and fragments
#1388Humanized antibodies against CEACAM1
#1389Humanized anti-CXCR5 antibodies, derivatives thereof and their uses
#1390Engineering of immunoglobulin domains
#1391Anti-MCAM antibodies and associated methods of use
#1392Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia
#1393Bispecific HER2 antibodies and methods of use
#1394Antibodies against human CSF-1R and uses thereof
#1395METHOD OF INHIBITION OF LEUKEMIC STEM CELLS
#1396IMMUNOGLOBULINS
#1397MULTISPECIFIC ANTIBODY ANALOGS COMPRISING A COMMON LIGHT CHAIN, AND METHODS OF THEIR PREPARATION AND USE
#1398Prolactin receptor binding proteins and uses thereof
#1399Multivalent and multispecific DR5-binding fusion proteins
#1400ANTI-NOTCH3 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
#1401Anti-MCAM antibodies and associated methods of use
#1402Polypeptides
#1403Anti-C5a binding moieties with high blocking activity
#1404PD-1 antibody, antigen-binding fragment thereof, and medical application thereof
#1405Humanized anti-CD22 antibody
#1406Use of an IL-17/IL-23 bispecific antibody for treating inflammation
#1407Methods of producing anti-C5a antibodies
#1408TYROSINE-PHOSPHORYLATED WBP2, A NOVEL CANCER TARGET AND BIOMARKER
#1409CYS80 conjugated immunoglobulins
#1410Anti-CTLA-4 antibodies and methods of use thereof
#1411Humanized and affinity matured antibodies to FcRH5 and methods of use
#1412Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
#1413CA6 antigen-specific cytotoxic conjugate and methods of using the same
#1414Methods of treating a tauopathy
#1415Acceptor framework for CDR grafting
#1416Anti-CD40 antibodies
#1417Antibodies against OX40 and uses thereof
#1418Animal models and therapeutic molecules
#1419Human C-FMS antigen binding proteins
#1420Antibodies to human GDF8
#1421Stable protein solution formulation containing high concentration of an anti-VEGF antibody
#1422Agents that specifically bind matrilin-3 and their use
#1423Baff selective binding compounds and related methods
#1424Humanized or chimeric CD3 antibodies
#1425Antigen binding proteins
#1426Neutralizing GP41 antibodies and their use
#1427Methods for treating rheumatoid arthritis by administering IL-6 receptor antibodies
#1428BIOLOGICAL PRODUCTS
#1429COMBINATION THERAPIES EMPLOYING GITR BINDING MOLECULES
#1430Methods of treatment with bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1
#1431Anti-CD19 antibodies
#1432Anti-PD-1 antibodies
#1433Polynucleotides encoding anti-kit antibodies
#1434Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof
#1435Treatment with anti-VEGF antibodies
#1436ACCEPTOR FRAMEWORK FOR CDR GRAFTING
#1437HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODIES TO CD47
#1438Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
#1439HUMAN ANTI-NGF NEUTRALIZING ANTIBODIES AS SELECTIVE NGF PATHWAY INHIBITORS
#1440TREATMENT WITH ANTI-VEGF ANTIBODIES
#1441Transgenic animal for production of antibodies having minimal CDRs
#1442Methods of treating neuropathic pain with specific binding members for NGF
#1443Amino acid sequences that modulate the interaction between cells of the immune system
#1444IL-17A binding agent and uses thereof
#1445Amino acid sequences that modulate the interaction between cells of the immune system
#1446Compositions and methods for diagnosing and treating an inflammation
#1447IL-13 BINDING PROTEINS AND USES THEREOF
#1448ANTI-NERVE GROWTH FACTOR ANTIBODIES AND METHODS OF PREPARING AND USING THE SAME
#1449Antibodies for treatment of cancer expressing claudin 6
#1450Altered APRIL binding antibodies
#1451Method for generation of immunoglobulin sequences
#1452ANTI-PODOCALYXIN ANTIBODIES AND METHODS OF USING THE SAME
#1453TEM8 antibodies and their use in treatment and detection of tumors
#1454ANTI-IL-12/IL-23 ANTIBODIES
#1455Glycans as functional cancer targets and antibodies thereto
#1456Antibody therapeutics that bind CD47
#1457Dual specific antibodies
#1458ANTI-VEGF ANTIBODIES
#1459ANTI-TRANSTHYRETIN ANTIBODIES
#1460IL-17 receptor A antigen binding proteins
#1461Anti-PD-1 antibodies
#1462Stable and soluble antibodies inhibiting TNF alpha
#1463ANTIBODIES RECOGNIZING MEDIN
#1464Humanized antibodies that recognize alpha-synuclein
#1465Antibody molecules to dengue virus and uses thereof
#1466Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
#1467Antibody libraries
#1468ANTIBODIES
#1469Methods for enhancing immunosuppressive therapy by multiple administration of αβTCR-binding polypeptide
#1470ANTIGEN RECEPTOR SCREENING ASSAY
#1471Binding molecules specific for HER3 and uses thereof
#1472NUCLEIC ACID ENCODING ANTI-PD-L1 ANTIBODIES
#1473Pen-injector device containing anti-IL-6 antibodies
#1474Gram-positive bacteria specific binding compounds
#1475Heterodimeric antibodies that bind CD3 and CD38
#1476Chicken antibody transformed into cysteine and site-specific conjugation using same
#1477Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU
#1478Anti-HIV domain antibodies and method of making and using same
#1479Non-immunogenic single domain antibodies
#1480ANTI-CD38 HUMAN ANTIBODIES AND USES THEREOF
#1481Binding molecules specific for CD73 and uses thereof
#1482Antibody derivatives
#1483Monoclonal antibodies to human 14-3-3 epsilon and human 14-3-3 epsilon sv
#1484Stable and soluble antibodies inhibiting TNFα
#1485INTERCALATED SINGLE-CHAIN VARIABLE FRAGMENTS
#1486Anti-GD2 antibodies
#1487TNF-ALPHA BINDING PROTEINS
#1488Compositions and methods for antibodies targeting BMP6
#1489Synthetic library of specific binding molecules
#1490Anti-FGFR3 antibodies and methods using same
#1491Humanized or chimeric CD3 antibodies
#1492Anti-interleukin-33 antibodies and uses thereof
#1493GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS
#1494Binding molecules specific for HER3 and uses thereof
#1495Anti-B7-H4 antibodies and immunoconjugates
#1496Methods of inhibiting growth of a colon cancer tumor in a subject by administering monoclonal antibodies to G protein-coupled receptor 49 (GPR49)
#1497Humanized antibody or fragment thereof specific for CD45R0
#1498Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
#1499Single domain binding molecule
#1500Construction of diverse synthetic peptide and polypeptide libraries